Supplemental material
Open access
1,195
Views
12
CrossRef citations to date
0
Altmetric
Short Communication
Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors
Guo-Liang QiuSchool of Pharmacy, Anhui Medical University, Hefei, PR China; View further author information
, Shao-Sheng HeSchool of Pharmacy, Anhui Medical University, Hefei, PR China; ;Lujiang County People's Hospital, Lujiang, Anhui, PR China; View further author information
, Shi-Chao ChenSchool of Pharmacy, Anhui Medical University, Hefei, PR China; View further author information
, Bo LiSchool of Pharmacy, Anhui Medical University, Hefei, PR China; View further author information
, Hui-Hui WuAnhui Prevention and Treatment Center for Occupational Disease, Hefei, PR ChinaView further author information
, Jing ZhangAnhui Prevention and Treatment Center for Occupational Disease, Hefei, PR ChinaCorrespondence[email protected]
View further author information
& View further author information
Wen-Jian TangSchool of Pharmacy, Anhui Medical University, Hefei, PR China; Correspondence[email protected]
View further author information
show allView further author information
Pages 1506-1515
|
Received 21 Mar 2018, Accepted 12 Jun 2018, Published online: 04 Oct 2018
Related Research Data
2016 Alzheimer's disease facts and figures
Source:
Wiley
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.
Source:
HAL CCSD
Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products.
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Structure-Based Search for New Inhibitors of Cholinesterases
Source:
MDPI AG
Butyrylcholinesterase Inhibitors
Source:
Wiley
Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors
Source:
Elsevier BV
Novel dihydropyrazole-chromen: Design and modulates hTERT inhibition proliferation of MGC-803.
Source:
Elsevier BV
4,5-Dihydro-1H-pyrazole: an indispensable scaffold.
Source:
Informa UK Limited
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Source:
Informa UK Limited
Novel 2H-chromen derivatives: design, synthesis and anticancer activity
Source:
Royal Society of Chemistry (RSC)
Cholinergic Dysfunction in Parkinson’s Disease
Source:
Springer Science and Business Media LLC
Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors
Source:
Taylor & Francis
Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.
Source:
Elsevier BV
Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors
Source:
Taylor & Francis
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
Source:
The University of North Carolina at Chapel Hill University Libraries
Design and synthesis of celastrol derivatives as anticancer agents.
Source:
Elsevier BV
Miniperspective
Source:
American Chemical Society (ACS)
Neuroscience: Alzheimer's disease.
Source:
Springer Science and Business Media LLC
Novel coumarin-dihydropyrazole thio-ethanone derivatives: Design, synthesis and anticancer activity
Source:
Elsevier BV
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.